Literature DB >> 31328471

Response to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control study.

Chun Che Huang1, Ching Heng Lin2,3,4.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31328471      PMCID: PMC6658595          DOI: 10.3802/jgo.2019.30.e109

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


× No keyword cloud information.
To the Editor, We appreciate and thank Dr. Oxley et al. [1] for their interest in our work [2] and comments. Their involvement in this field makes them placed to contribute to these discussions. While we understand their concerns, we respectfully disagree with their interpretation of our analytic approach and conclusions. One major concern was that the confidence of the findings was affected by inclusion criteria for uterine myoma and unmeasured confounders. However, a definitive diagnosis with International Classification of Diseases, 9th revision, clinical modification (ICD-9-CM) codes in the administrative data has important implications for the treatment of women with prior uterine myoma; thus, our patient selection criteria must be as precise as possible to weed out potential errors and increase diagnostic accuracy. In addition, to minimize selection bias, frequency matching can ensure that cases and controls have the same frequencies of exposure to potentially confounding factors for comparison [3]. Although other unmeasured factors may influence the results, these findings have important implications for understanding the impact of prior uterine myoma on the development of subsequent ovarian cancer. Another concern was criticism of the results for ovarian cancer patients with prior uterine myoma and those who underwent myomectomy and their use of medical care services. However, this may be an over-interpretation of our results. In fact, Melin et al. [4] reported that women who underwent radical surgical extirpation of endometriosis had a lower risk of ovarian cancer. It is possible that removing endometriotic tissue would reduce inflammation in the pelvic cavity and then lower risk of developing ovarian malignant. Their last concern was that exposure to negative information about uterine myoma risk may increase women's anxiety. Even if we cannot draw definitive conclusions, we believe that women with prior uterine myoma should be made aware of the potential conditions that result in an increased risk of ovarian cancer development. In addition, identification of patients at increased risk is essential and further studies are needed to clarify the mechanisms underlying the effects of uterine myoma on the pathogenesis of ovarian cancer.
  4 in total

1.  Longitudinal studies 4: Matching strategies to evaluate risk.

Authors:  Matthew T James
Journal:  Methods Mol Biol       Date:  2015

2.  Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer.

Authors:  Anna-Sofia Melin; Cecilia Lundholm; Ninoa Malki; Marja-Liisa Swahn; Pär Sparèn; Agneta Bergqvist
Journal:  Acta Obstet Gynecol Scand       Date:  2013-04-08       Impact factor: 3.636

3.  Letter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control study.

Authors:  Samuel George Oxley; Fusun Sirkeci; Funlayo Odejinmi
Journal:  J Gynecol Oncol       Date:  2019-09       Impact factor: 4.401

4.  Prior uterine myoma and risk of ovarian cancer: a population-based case-control study.

Authors:  Jenn Jhy Tseng; Chun Che Huang; Hsiu Yin Chiang; Yi Huei Chen; Ching Heng Lin
Journal:  J Gynecol Oncol       Date:  2019-09       Impact factor: 4.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.